1 December 2020 in International Journal of Infectious Diseases
AYAyşegul Karahasan Yagci
+7
Studies analyzing viral load in COVID-19 patients and any data that compare viral load with chest computerized tomography (CT) severity are limited. This study aimed to evaluate the severity of chest CT in reverse transcriptase polymerase chain reaction (RT-PCR)-positive patients and factors associated with it. SARS-CoV-2 RNA was extracted from nasopharyngeal swab samples by using Bio-speedy viral nucleic acid buffer. The RT-PCR tests were performed with primers and probes targeting the RdRp gene (Bioexen LTD, Turkey) and results were quantified as cycle threshold (Ct) values. Chest CT of SARS-CoV-2 RNA-positive patients (n = 730) in a period from 22 March to 20 May 2020 were evaluated. The total severity score (TSS) of chest CT ranged 0–20 and was calculated by summing up the degree of acute lung inflammation lesion involvement of each of the five lung lobes. Of the 284 patients who were hospitalized, 27 (9.5%) of them died. Of 236 (32.3%) patients, there were no findings on CT and 216 (91.5%) of them were outpatients (median age 35 years). TSS was significantly higher in hospitalized patients; 5.3% had severe changes. Ct values were lower among outpatients, indicating higher viral load. An inverse relation between viral load and TSS was detected in both groups. CT severity was related to age, and older patients had higher TSS (p < 0.01). Viral load was not a critical factor for hospitalization and mortality. Outpatients had considerable amounts of virus in their nasopharynx, which made them contagious to their contacts. Viral load is important in detecting early stages of COVID-19, to minimize potential spread, whereas chest CT can help identify cases requiring extensive medical care.
1 December 2019 in Radiology Case Reports
ZAZahra Abdulaziz N. Almoabid
Zahra Abdulaziz N. Almoabid
The distinction between tuberculous peritonitis and peritoneal carcinomatosis is extremely difficult in patients with omental cake appearance on computed tomography and elevated CA-125 level. A 21-year-old female presented with abdominal distention, diarrhea, nausea, fever, weight loss, and night sweats. Serum CA-125 level was 563 U/L (normal range: <35 U/L) and other tumor markers were within normal range. Radiologic studies showed massive ascites, smooth minimal thickening and increased contrast enhancement of peritoneum, omental nodularities, hepatomegaly, and right pleural effusion. No underlying malignancy that could cause this condition was detected clinically and radiologically. Ultrasound-guided omental tru-cut biopsy was performed to exclude carcinomatosis peritonei. Histopathologic examination showed small-medium-sized granulomas with caseous necrosis. Molecular microbiology tests of biopsy specimens confirmed diagnosis of tuberculosis. In conclusion, tuberculous peritonitis should be in differential diagnosis of a patient with ascites, omental nodularities and elevated serum CA-125 levels.
1 December 2019 in Radiology Case Reports
Small bowel obstruction caused by myeloid sarcoma in a patient with any hematological abnormality is very rare. Myeloid sarcoma occurs most commonly in patients with acute myelogenous leukemia (AML) and less with other hematological disorders. A 57-year-old female presented with abdominal pain, nausea, vomiting, and constipation. Radiological studies showed concentric bowel thickening in distal ileum that caused nearly total luminal compromise and signs of obstruction in proximal ileal bowel loops. She underwent laparotomic surgery and ileal resection was done. Diagnosis of myeloid sarcoma was made by histopathological examination of surgical specimens. Bone marrow biopsy was done to rule out systemic acute myelogenous leukemia (AML). Results of bone marrow biopsy were within normal limits. Finally, the patient was diagnosed as de novo myeloid sarcoma. Although the histopathological examination makes a definitive diagnosis, imaging allows to locate the lesion, evaluate its complications, and guide for correct biopsy. Accurate diagnosis of myeloid sarcoma has important prognostic value as transformation to AML can happen without chemotherapy or stem cell transplantation.
12 February 2025 in Pediatric Radiology
27 September 2021 in Child's Nervous System
23 February 2026 in Journal of Computer Assisted Tomography
Objective: To assess the impact of split-bolus (SB) single scan CT on the conspicuity of clear cell renal cell carcinoma (ccRCC) metastases compared with single-bolus injection. Methods: This retrospective cohort study included consecutive patients with histologically proven metastatic ccRCC who underwent both SB and single-bolus portal venous abdominal CT within 6 months between 2017 and 2022 in a single tertiary center. SB CT utilized BMI-adjusted contrast dose and kVp (80 to 120) with concurrent arterial and portal venous phases. Single bolus CT utilized BMI-adjusted contrast dose at 120 kVp at the portal venous phase. Wilcoxon rank test compared the conspicuity of metastases between the protocols. Results: Of the 47 patients, 80.9% were male, with a mean age of 67±10.4 years and a BMI of 27.1±5.7. There were 48 paired CTs performed with a median interval of 93 days. Contrast dose was 143±27 ml for SB and 108±26 ml for single-bolus ( P <0.001). Sixty-six metastases were analyzed, with an average size of 2 cm: 48.5% in the pancreas, 28.8% in skeletal muscle, and 22.7% in the liver. The median contrast-to-noise ratio (CNR) was higher with SB compared with single-bolus for all metastases (3.0 vs. 1.4), pancreatic metastases (2.7 vs. 1.4), muscle metastases (5.2 vs. 2.0), and liver metastases (2.8 vs. 0.9), all P <0.001. Conclusions: SB scan provides dramatically higher conspicuity of ccRCC metastases as compared with single-bolus portal venous CT.